13C magnetic
resonance spectroscopic imaging (13C-MRSI)
is a promising technique for elucidating metabolic heterogeneity in breast
cancer. We used 13C-MRSI to evaluate the extent of glycolysis in different
histologic and molecular breast cancer subtypes and correlated these findings
with the expression of a key transmembrane transporter (MCT1) and glycolytic
enzyme (LDHA). In addition to a strong correlation between glycolysis and tumor
volume, there was higher expression of MCT1 and LDHA as well as CAIX, a hypoxia
marker, in the more glycolytic tumors. This is the first study in humans to demonstrate
the relationship between intertumoral heterogeneity on gene expression analysis
and 13C-MRSI.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords